Wednesday, November 16, 2005

Biotech In The Triangle

It looks like the Biotech industry is continuing to grow in the Triangle.

Apparently, Roche, the Swiss drug maker that produces Tamiflu is eyeing Holly Springs for a $750 million plant.

This would be in addition to the $300 million Merck plant being built in Durham and the $190 million expansion to GlaxoSmithLine in Zebulon.

Triangle Business Journal Article

No comments:

Post a Comment